There are currently three generic Nor-QD products available on the market. These generic birth control pills are sold under the names Camila, Heather, and Nora-BE. In tests conducted by the FDA, all generic versions were shown to be equivalent to the brand-name version. However, generic Nor-QD products are allowed to have different inactive ingredients, which could cause problems for people with allergies or sensitivities.
Is Generic Nor-QD Available?
Nor-QD® (norethindrone) is one of the many birth control pills available. It belongs to a group of medications known as progestin-only pills, named because they contain only a progestin hormone (they do not contain an estrogen hormone). Progestin-only birth control pills are not more effective than other birth control pills, but are preferred for breastfeeding women and women at risk for blood clots and heart disease.
Nor-QD is made by Watson Pharmaceuticals, Inc. and is available in generic form. Generic versions of Nor-QD are sold under what looks like other brand names, not the typical "generic" names that most other types of medications use.
Names of Generic Nor-QD
Currently, generic Nor-QD is sold under the names Camila® (made by Barr Laboratories), Heather® (made by Glenmark Generics), and Nora-BE® (made by Watson Pharmaceuticals, the same company that makes Nor-QD). The generic names of birth control pills can be confusing. The names are long, and different products can have the same generic name, even though they may be quite different. To avoid confusion, manufacturers of generic birth control pills give their versions a "brand name" instead of using the standard generic name. These products are still generics, even though they seem like brand-name products, due to their names. It can be difficult to tell if a particular birth control pill is generic or brand-name, although the price is often a good indication (with generics usually costing significantly less).
Food and Drug Administration, Center for Drug Evaluation and Research. Electronic orange book: approved drug products with therapeutic equivalence evaluations. FDA Web site. Available at: http://www.fda.gov/cder/ob/. Accessed July 8, 2013.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind.
Site users seeking medical advice about their specific situation should consult with their own physician. Click